MAKING A DEAL: Dexa Medica Group, a leading Indonesian

MAKING A DEAL: Dexa Medica Group, a leading Indonesian pharmaceutical company, signed on July 1 a cooperation agreement with DR. Reddy's Laboratories, based in India, for marketing oncology and biotechnology products. PT Ferron Par Pharmaceuticals, a member of Dexa Medica Group, will register several DR. Reddy's oncology products with the Food and Drug Monitoring Agency and market the products via distributor Anugrah Argon Medica. PT Dexa Medica will market biotechnology products in several therapeutic categories. Pictured above (left to right) are: Ferry Soetikno, Managing Director of PT Dexa Medica; Satish Reddy, Managing Director and COO of DR. Reddy's Laboratories; and Djoko Sujono, Managing Director of PT Ferron Par Pharmaceuticals.